Effective inhibition of glycolysis in venous whole blood and plasma samples;Effektive Glykolyse-Inhibierung im Citrat-gepufferten venösen Vollblut und Plasma

LaboratoriumsMedizin

Volumn 36, Issue 3, 2012, Pages 169-177

  Yagmur, Eray ^a   Van Helden, Josef ^a   Koch, Alexander ^b   Jadem, Johny ^a   Tacke, Frank ^b   Trautwein, Christian ^b  

^a MVZ Dr Stein+Kollegen   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

acidification; citrate buffer; glycolysis; venous plasma

Indexed keywords

CITRIC ACID; FLUORIDE SODIUM; GLUCOSE;

ARTICLE; BLOOD SAMPLING; CENTRIFUGATION; CONTROLLED STUDY; DILUTION; GLUCOSE BLOOD LEVEL; GLYCAEMIA TUBE; GLYCOLYSIS; HEMATOCRIT; HUMAN; HUMAN EXPERIMENT; LINEAR REGRESSION ANALYSIS; MEDICAL DEVICE; NORMAL HUMAN; RANK SUM TEST; TUBE; VENOUS BLOOD;

EID: 84861370105     PISSN: 03423026     EISSN: 14390477     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Crowther C, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, ACHOIS Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477-86.
2. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339-48.
3. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al., HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002.
4. Chan AY, Swaminathan R, Cockram CS. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem 1989;35:315-7.
5. Gambino R. Glucose: A simple molecule that is not simple to quantify. Clin Chem 2007;53:2040-1.
6. Mikesh LM, Bruns DE. Stabilization of glucose in blood specimens: Mechanism of delay in fluoride inhibition of glycolysis. Clin Chem 2008;54:930-1.
7. Bruns DE, Knowler WC. Stabilization of glucose in blood samples: Why it matters. Clin Chem 2009;55:850-2.
8. Gambino R, Piscitelli J, Ackattupathil TA, Theriault JL, Andrin RD, Sanfilippo ML, et al. Acidification of blood is superior to sodium fluoride alone as an inhibitor of glycolysis. Clin Chem 2009;55:1019-21.
9. Kleinwechter H, Sch ä fer-Graf U, B ü hrer C, Hoesli I, Kainer F, Kautzky-Willer A, et al. Gestationsdiabetes melltius (GDM). Evidenzbasierte Leitlinie zu Diagnostik, Therapie und Nachsorge der Deutschen Diabetes-Gesellschaft (DDG) und der Deutschen Gesellschaft für Gyn ä kologie und Geburtshilfe (DGGG).2011.
10. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Position statement: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011;34:1419-23.
11. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33: 676-82.
12. Standards of medical care in diabetes-2010. Diabetes Care 2010;33(Suppl 1):S11-61.
13. Haeckel R, Brinck U, Colic D, Janka H, Pl ü ntmann I, Schneider J, et al. Comparability of blood glucose concentration measured in different sample systems for detecting glucose intolerance. Clin Chem 2002;48:936-9.
14. Kerner W, Brückel J. Definition, Klassifikation und Diagnostik des Diabetes mellitus. Diabetologie und Stoffwechsel 2008;3:131-3.
15. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-73.
16. Richtlinien des Bundesausschusses der Ä rzte und Krankenkassen ü ber die ä rztliche Betreuung w ä hrend der Schwangerschaft und nach der Entbindung ("Mutterschafts-Richtlinien "). Ver öffentlicht im Bundesanzeiger Nr. 36, S. 914. In Kraft getreten am 03. M ä rz 2012.
17. Waring WS, Evans LE, Kirkpatrick CT. Glycolysis inhibitors negatively bias blood glucose measurements: Potential impact on the reported prevalence of diabetes mellitus. J Clin Pathol 2007;60:820-3.
18. Feig SA, Shohet SB, Nathan DG. Energy metabolism in human erythrocytes, I: Effects of sodium fluoride. J Clin Invest 1971;50:1731-7.
19. Stahl M, J ø rgensen LG, Hyltoft Petersen P, Brandslund I, De Fine Olivarius N, Borch-Johnsen K. Optimization of preanalytical conditions and analysis of plasma glucose. 1. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Clin Lab Invest 2001;61:169-79.
20. Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T, et al. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 2005;353:1454-62.
21. Uchida K, Okuda S, Tanaka K, inventors; Terumo Corporation, assignee. Method of inhibiting glycolysis in blood samples. US patent 4,780,419. 1988 Oct 4. 20 .
22. Chapman BE, Kuchel PW. Fluoride transmembrane exchange in human erythrocytes measured with 19F NMR magnetization transfer. Eur Biophys J 1990;19:41-5.
23. Gambino R, Reichberg S, Schwartz JG. Normal fasting plasma glucose level and type 2 diabetes. N Engl J Med 2006;354:87-8.
24. Troisi RJ, Cowie CC, Haris MI. Diurnal variation in fasting plasma glucose. Implications for diagnosis of diabetes in patients examined in the afternoon. J Am Med Assoc 2000;284: 3157-9.